EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
Press releases
May 10, 2021
Terasaki Institute Memorandum of Uderstanding
“The Terasaki Institute leads the world in the development of bioprintable, biopolymer-based technologies poised to revolutionize drug delivery, wearable and implantable devices. Jointly with HTL we expect to bring to life a new generation of biopolymer-based applications in critical sectors of precision and regenerative medicine,” added Maurizio Vecchione, Chief Innovation Officer of the Terasaki Institute for Biomedical Innovation.
Read more below.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles April 13, 2026EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
-
Articles March 19, 2026HTL Biotechnology at PCHi 2026 in Hangzhou
HTL Biotechnology recently took part in PCHi (Personal Care and Homecare Ingredients), one of the leading events for the personal care industry, held in Hangzhou, China.
-
Articles February 16, 2026Lunar New Year 2026: Entering the Year of the Fire Horse
From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
A time of renewal, ambition, and fresh opportunities for growth.